针对热带寄生虫病的疫苗：持久应对持久问题的答案。
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem.
机构信息
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Nat Immunol. 2014 May;15(5):403-5. doi: 10.1038/ni.2853.
Abstract
Live and live-attenuated whole organism vaccines against malaria and cutaneous leishmaniasis due to remain the most uniformly effective vaccines against human parasitic diseases. These vaccines are discussed in terms of the nature of the T cell populations that mediate the strong and durable localized immunity to these infections, and the requirement for persisting antigen to generate and maintain the protective response. The difficulties in developing subunit vaccines that fulfill this requirement argue that despite their own formidable problems in manufacture and delivery, live and live- attenuated whole organism vaccines against human parasitic diseases should be vigorously pursued.
摘要
针对疟疾和皮肤利什曼病的活疫苗和减毒活疫苗仍然是针对人体寄生虫病最有效、最普遍的疫苗。本文将讨论介导针对这些感染的强烈和持久局部免疫的 T 细胞群体的性质，以及产生和维持保护反应所需的持续抗原。开发符合这一要求的亚单位疫苗存在困难，这表明，尽管活疫苗和减毒活疫苗在制造和使用方面存在自身的巨大问题，但仍应大力研究针对人体寄生虫病的活疫苗和减毒活疫苗。
相似文献
1
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem.针对热带寄生虫病的疫苗：持久应对持久问题的答案。
Nat Immunol. 2014 May;15(5):403-5. doi: 10.1038/ni.2853.
2
The Delay in the Licensing of Protozoal Vaccines: A Comparative History.原生动物疫苗的许可延迟：比较历史。
Front Immunol. 2020 Mar 6;11:204. doi: 10.3389/fimmu.2020.00204. eCollection 2020.
3
Experimental models in vaccine research: malaria and leishmaniasis.疫苗研究中的实验模型：疟疾和利什曼病
Braz J Med Biol Res. 2013 Feb;46(2):109-16. doi: 10.1590/1414-431x20122460. Epub 2013 Feb 1.
4
[The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].[与抗疟疫苗研发相关的热带疟疾免疫学方面]
Med Parazitol (Mosk). 2000 Apr-Jun(2):56-8.
5
Vaccines against the blood stages of falciparum malaria.针对恶性疟原虫血液阶段的疫苗。
Adv Exp Med Biol. 1998;452:193-205. doi: 10.1007/978-1-4615-5355-7_22.
6
An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum.一种基于人类白细胞抗原（HLA）设计诱导针对恶性疟原虫细胞毒性T淋巴细胞（CTL）疫苗的方法。
Res Immunol. 1994 Jul-Aug;145(6):461-8. doi: 10.1016/s0923-2494(94)80177-0.
7
Antibodies and Plasmodium falciparum merozoites.抗体与恶性疟原虫裂殖子
Trends Parasitol. 2001 Apr;17(4):194-7. doi: 10.1016/s1471-4922(00)01946-2.
8
Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?基于恶性疟原虫裂殖子表面蛋白3的疟疾疫苗——我们应该避开氨基酸序列多态性还是欣然接受它们？
J Infect Dis. 2007 Jan 15;195(2):171-3. doi: 10.1086/509813. Epub 2006 Dec 13.
9
Characterization of immune reactivity profiles using microarray technology may expedite identification of candidate antigens for next generation malaria vaccines.使用微阵列技术表征免疫反应谱可能会加快下一代疟疾疫苗候选抗原的鉴定。
Clin Chem. 2007 Jul;53(7):1183-5. doi: 10.1373/clinchem.2007.087049.
10
Overview: immunology of malaria and progress in malaria vaccine development.概述：疟疾免疫学与疟疾疫苗研发进展
Southeast Asian J Trop Med Public Health. 1992 Sep;23 Suppl 4:71-87.
引用本文的文献
1
Live attenuated-nonpathogenic and DNA structures as promising vaccine platforms against leishmaniasis: innovations can make waves.减毒活疫苗-非致病性和DNA结构作为抗利什曼病的有前景的疫苗平台：创新能够引发轰动。
Front Microbiol. 2024 Apr 3;15:1326369. doi: 10.3389/fmicb.2024.1326369. eCollection 2024.
2
Antigen recognition reinforces regulatory T cell mediated Leishmania major persistence.抗原识别增强调节性 T 细胞介导的利什曼原虫的持久性。
Nat Commun. 2023 Dec 19;14(1):8449. doi: 10.1038/s41467-023-44297-6.
3
Immunoinformatics Approach to Design a Multi-Epitope Vaccine against Cutaneous Leishmaniasis.用于设计抗皮肤利什曼病多表位疫苗的免疫信息学方法
Vaccines (Basel). 2023 Feb 2;11(2):339. doi: 10.3390/vaccines11020339.
4
Healed Lesions of Human Cutaneous Leishmaniasis Caused By Do Not Shelter Persistent Residual Parasites.人类皮肤利什曼病的愈合病变不会庇护持续残留的寄生虫。
Front Cell Infect Microbiol. 2022 Jul 27;12:839216. doi: 10.3389/fcimb.2022.839216. eCollection 2022.
5
Innate immune cell response to host-parasite interaction in a human intestinal tissue microphysiological system.先天免疫细胞对人类肠道组织器官芯片中宿主-寄生虫相互作用的反应。
Sci Adv. 2022 May 6;8(18):eabm8012. doi: 10.1126/sciadv.abm8012.
6
Epileptogenesis in Common Parasitic Infections.常见寄生虫感染中的致痫发生。
Curr Neurol Neurosci Rep. 2022 Apr;22(4):285-291. doi: 10.1007/s11910-022-01187-6. Epub 2022 Mar 25.
7
Non-Canonical Host Intracellular Niche Links to New Antimicrobial Resistance Mechanism.非经典宿主细胞内生态位与新的抗菌耐药机制相关。
Pathogens. 2022 Feb 8;11(2):220. doi: 10.3390/pathogens11020220.
8
Comparative analyses of parasites with a comprehensive database of genome-scale metabolic models.寄生虫的综合数据库与基因组规模代谢模型的比较分析。
PLoS Comput Biol. 2022 Feb 23;18(2):e1009870. doi: 10.1371/journal.pcbi.1009870. eCollection 2022 Feb.
9
Genetic mapping reveals Nfkbid as a central regulator of humoral immunity to Toxoplasma gondii.遗传图谱显示 Nfkbid 是弓形虫体液免疫的中心调节因子。
PLoS Pathog. 2021 Dec 6;17(12):e1010081. doi: 10.1371/journal.ppat.1010081. eCollection 2021 Dec.
10
Enhanced Detection of -Specific T Cells in Experimentally-Infected Cattle.实验感染牛中特异性T细胞的增强检测
Front Vet Sci. 2021 Jul 14;8:676710. doi: 10.3389/fvets.2021.676710. eCollection 2021.
本文引用的文献
1
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. chimpanzee 腺病毒-MVA 免疫诱导的对人疟疾的保护性 CD8+ T 细胞免疫。
Nat Commun. 2013;4:2836. doi: 10.1038/ncomms3836.
2
Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c.经基因减毒疟原虫疫苗接种诱导的寿命短的效应性 CD8 T 细胞表达 CD11c。
Infect Immun. 2013 Nov;81(11):4171-81. doi: 10.1128/IAI.00871-13. Epub 2013 Aug 26.
3
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.经静脉免疫接种非复制性疟原虫疫苗预防疟疾。
Science. 2013 Sep 20;341(6152):1359-65. doi: 10.1126/science.1241800. Epub 2013 Aug 8.
4
New vaccines for neglected parasitic diseases and dengue.新型疫苗可预防被忽视的寄生虫病和登革热。
Transl Res. 2013 Sep;162(3):144-55. doi: 10.1016/j.trsl.2013.03.006. Epub 2013 Apr 8.
5
CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation.感染后 CD4+ T 细胞的持久性和功能由低水平的肽:MHC Ⅱ类呈递维持。
J Immunol. 2013 Mar 15;190(6):2828-34. doi: 10.4049/jimmunol.1202183. Epub 2013 Feb 4.
6
Peripheral tissue surveillance and residency by memory T cells.记忆 T 细胞对周围组织的监测和驻留。
Trends Immunol. 2013 Jan;34(1):27-32. doi: 10.1016/j.it.2012.08.008. Epub 2012 Oct 2.
7
Immunological memory ≠ protective immunity.免疫记忆≠保护性免疫。
Cell Mol Life Sci. 2012 May;69(10):1635-40. doi: 10.1007/s00018-012-0972-y. Epub 2012 Apr 6.
8
Vaccines against malaria.疟疾疫苗。
Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2806-14. doi: 10.1098/rstb.2011.0091.
9
Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development.诱导和维持针对疟疾肝期的保护性 CD8+ T 细胞：对疫苗开发的启示。
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1(0 1):172-8. doi: 10.1590/s0074-02762011000900022.
10
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.实验性疟原虫接种后对疟疾的长期保护作用：一项开放性随访研究。
Lancet. 2011 May 21;377(9779):1770-6. doi: 10.1016/S0140-6736(11)60360-7. Epub 2011 Apr 22.
Zotero 插件